Midodrine Hydrochloride Teva (Midodrine Hydrochloride)

Midodrine is a prodrug that is converted to desglymidodrine, which selectively activates alpha‑1 adrenergic receptors on blood vessels. This activation causes vasoconstriction, increasing peripheral resistance and thereby elevating blood pressure, especially when a patient moves to an upright position.

The dosage of Midodrine Hydrochloride Teva is individualized by the prescribing clinician based on the patient’s blood pressure response, severity of symptoms, and tolerability. The prescriber determines the appropriate strength, frequency, and duration of therapy.

The safety of Midodrine Hydrochloride Teva in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Midodrine is unique as an oral alpha‑1 adrenergic agonist that directly increases vascular tone. Other antihypotensive options, such as fludrocortisone, act by expanding blood volume. Choice of therapy depends on patient-specific factors, including comorbidities, side‑effect profile, and clinician preference.

Midodrine Hydrochloride Teva tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Do not store in a refrigerator or freezer.

The medication is taken orally as a tablet, usually with a full glass of water. Doses are generally spaced throughout the day, and the last dose should be taken at least four hours before bedtime to reduce the risk of supine hypertension.

The most serious risks include severe supine hypertension, which can lead to cardiovascular complications, and rare but serious cardiac events such as arrhythmias or myocardial ischemia. Patients should be monitored closely for any signs of excessive blood pressure elevation.

Midodrine is contraindicated in patients with severe organic heart disease, acute renal failure, urinary retention, pheochromocytoma, or known hypersensitivity to the drug. It should also be avoided in individuals who cannot safely monitor their blood pressure.